FDA outlines 45-day review period before TV ads air

03/12/2012 | Medical Marketing & Media

Drugmakers should submit proposed direct-to-consumer television ads to the FDA Center for Drug Evaluation and Research or Center for Biologics Evaluation and Research for review before airing them, according to a draft guidance from the agency. The FDA has 45 days from the date a complete package is received for review and will notify the sponsor if the review will not be completed on time. "This guidance creates an FDA 'shot clock' that doesn't allow you to take a shot at broadcast marketing for an additional 45 days," said Coalition for Healthcare Communication Executive Director John Kamp.

View Full Article in:

Medical Marketing & Media

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX